Cargando…
Inhibition of PKCθ Improves Dystrophic Heart Phenotype and Function in a Novel Model of DMD Cardiomyopathy
Chronic cardiac muscle inflammation and subsequent fibrotic tissue deposition are key features in Duchenne Muscular Dystrophy (DMD). The treatment of choice for delaying DMD progression both in skeletal and cardiac muscle are corticosteroids, supporting the notion that chronic inflammation in the he...
Autores principales: | Morroni, Jacopo, Schirone, Leonardo, Valenti, Valentina, Zwergel, Clemens, Riera, Carles Sánchez, Valente, Sergio, Vecchio, Daniele, Schiavon, Sonia, Ragno, Rino, Mai, Antonello, Sciarretta, Sebastiano, Lozanoska-Ochser, Biliana, Bouchè, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880527/ https://www.ncbi.nlm.nih.gov/pubmed/35216371 http://dx.doi.org/10.3390/ijms23042256 |
Ejemplares similares
-
Targeting PKCθ Promotes Satellite Cell Self-Renewal
por: Benedetti, Anna, et al.
Publicado: (2020) -
Accelerating the Mdx Heart Histo-Pathology through Physical Exercise
por: Morroni, Jacopo, et al.
Publicado: (2021) -
Lack of PKCθ Promotes Regenerative Ability of Muscle Stem Cells in Chronic Muscle Injury
por: Fiore, Piera Filomena, et al.
Publicado: (2020) -
Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy
por: Marrocco, V., et al.
Publicado: (2017) -
Muscle Diversity, Heterogeneity, and Gradients: Learning from Sarcoglycanopathies
por: Sánchez Riera, Carles, et al.
Publicado: (2021)